Stay updated on Medicenna Therapeutics Press Releases

Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Medicenna Therapeutics Press Releases page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a new News Release dated October 23, 2025 about updated MDNA11 clinical data to be presented at the ESMO Immuno-Oncology Congress 2025. Deleted the earlier News Release dated July 31, 2025 announcing five patents granted for IL-2 and IL-4 superkines.
    Difference
    3%
    Check dated 2025-10-26T20:19:37.000Z thumbnail image
  3. Check
    34 days ago
    Change Detected
    Summary
    - Add: new date (October 1, 2025) and announcement of Medicenna’s participation in the ROTH Healthcare Opportunities Conference. - Remove: old date (April 30, 2025) and the previous AACR preclinical data press release.
    Difference
    50%
    Check dated 2025-10-05T06:36:31.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Changed focus from ABILITY-1 trial results announced at AACR 2025 and an April 28, 2025 date to Medicenna’s annual meeting result announced on September 25, 2025 (and page 3 reference).
    Difference
    51%
    Check dated 2025-09-28T02:50:29.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page has been updated to reflect Medicenna's participation in the H.C. Wainwright 27th Annual Global Investment Conference on September 5, 2025, while the previous event at the 2025 Bloom Burton & Co. Healthcare Investor Conference has been removed.
    Difference
    53%
    Check dated 2025-09-06T14:14:10.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The web page has introduced the Medicenna AI Investor Assistant, which provides investors with a unified interface for accessing company data, including financial summaries and strategic updates.
    Difference
    80%
    Check dated 2025-08-30T11:10:26.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Medicenna Therapeutics has reported its first quarter fiscal 2026 financial results and operational highlights, and has strengthened its intellectual property portfolio with five new patents. Notably, previous announcements regarding upcoming presentations and clinical updates have been removed.
    Difference
    93%
    Check dated 2025-08-01T19:09:32.000Z thumbnail image

Stay in the know with updates to Medicenna Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.